Related Stories

Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…

The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…

The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s…

An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija….

Levodopa infusion pump We evaluate an ultraconcentrated levodopa administered subcutaneously in patients with motor fluctuations….

Our Unit has achieved to be activated in this outstanding project and so serious pathology….

We have been activated in this trial that evaluates the safety of an innovative compound…

We have reached the first position, in December 2019, in the international inclusion of patients…